21-46643598-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_206962.4(PRMT2):āc.103T>Cā(p.Phe35Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000661 in 151,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_206962.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRMT2 | NM_206962.4 | c.103T>C | p.Phe35Leu | missense_variant | 4/12 | ENST00000355680.8 | NP_996845.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000661 AC: 1AN: 151270Hom.: 0 Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome AF: 0.00000661 AC: 1AN: 151270Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 73782
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2024 | The c.103T>C (p.F35L) alteration is located in exon 4 (coding exon 2) of the PRMT2 gene. This alteration results from a T to C substitution at nucleotide position 103, causing the phenylalanine (F) at amino acid position 35 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at